More studies evaluating the role and utility of circulating, hepatic, and tumor TNF-α, specifically in patients with NAFLD-associated HCC, are warranted in the future to better define the association between circulating TNF-α with hepatic TNF-α from both malignant and healthy hepatic tissues. The gene discussed is TNF; the disease is hepatocellular carcinoma.